$ORGO
Organogenesis Holdings Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024125431 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $115.2M
YoY Change 6.12%
Cost Of Revenue $26.80M
YoY Change 3.9%
Gross Profit $88.38M
YoY Change 6.82%
Gross Profit Margin 76.73%
Selling, General & Admin $71.80M
YoY Change 11.79%
% of Gross Profit 81.23%
Research & Development $10.34M
YoY Change -1.2%
% of Gross Profit 11.7%
Depreciation & Amortization $3.570M
YoY Change 40.33%
% of Gross Profit 4.04%
Operating Expenses $82.14M
YoY Change 9.97%
Operating Profit $6.242M
YoY Change -22.46%
Interest Expense -$471.0K
YoY Change -206.08%
% of Operating Profit -7.55%
Other Income/Expense, Net -$419.0K
YoY Change 1.45%
Pretax Income $5.823M
YoY Change -23.75%
Income Tax -$6.508M
% Of Pretax Income -111.76%
Net Earnings $12.33M
YoY Change 289.36%
Net Earnings / Revenue 10.71%
Basic Earnings Per Share $0.09
Diluted Earnings Per Share $0.09
COMMON SHARES
Basic Shares Outstanding 132.6M 132.6M
Diluted Shares Outstanding 133.9M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $94.34M
YoY Change -3.93%
Cash & Equivalents $94.34M
Short-Term Investments
Other Short-Term Assets $15.86M
YoY Change 55.5%
Inventory $27.04M
Prepaid Expenses
Receivables $101.3M
Other Receivables $0.00
Total Short-Term Assets $238.5M
YoY Change 5.73%
LONG-TERM ASSETS
Property, Plant & Equipment $89.87M
YoY Change -23.52%
Goodwill $28.77M
YoY Change 0.0%
Intangibles $13.30M
YoY Change -22.22%
Long-Term Investments
YoY Change
Other Assets $5.013M
YoY Change 279.49%
Total Long-Term Assets $207.8M
YoY Change -12.35%
TOTAL ASSETS
Total Short-Term Assets $238.5M
Total Long-Term Assets $207.8M
Total Assets $446.3M
YoY Change -3.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.97M
YoY Change -10.5%
Accrued Expenses $36.10M
YoY Change 3.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $7.111M
YoY Change 6.13%
Total Short-Term Liabilities $77.28M
YoY Change -5.16%
LONG-TERM LIABILITIES
Long-Term Debt $57.17M
YoY Change -11.09%
Other Long-Term Liabilities $1.294M
YoY Change 8.65%
Total Long-Term Liabilities $1.294M
YoY Change 8.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $77.28M
Total Long-Term Liabilities $1.294M
Total Liabilities $167.7M
YoY Change -9.71%
SHAREHOLDERS EQUITY
Retained Earnings -$47.78M
YoY Change 18.27%
Common Stock $326.3M
YoY Change 2.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $278.5M
YoY Change
Total Liabilities & Shareholders Equity $446.3M
YoY Change -3.53%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $12.33M
YoY Change 289.36%
Depreciation, Depletion And Amortization $3.570M
YoY Change 40.33%
Cash From Operating Activities $8.695M
YoY Change -48.03%
INVESTING ACTIVITIES
Capital Expenditures $2.569M
YoY Change -57.04%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.569M
YoY Change -57.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.677M
YoY Change 16.46%
NET CHANGE
Cash From Operating Activities 8.695M
Cash From Investing Activities -2.569M
Cash From Financing Activities -1.677M
Net Change In Cash 4.449M
YoY Change -52.21%
FREE CASH FLOW
Cash From Operating Activities $8.695M
Capital Expenditures $2.569M
Free Cash Flow $6.126M
YoY Change -43.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001661181
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2024#AccountingStandardsUpdate201613Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37906
dei Entity Registrant Name
EntityRegistrantName
ORGANOGENESIS HOLDINGS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1329150
dei Entity Address Address Line1
EntityAddressAddressLine1
85 Dan Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Canton
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02021
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
575-0775
dei Security12b Title
Security12bTitle
Class A Common Stock, $0.0001 par value
dei Trading Symbol
TradingSymbol
ORGO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
132576502
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94340000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103840000
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
586000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
498000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
101272000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81999000
CY2024Q3 us-gaap Inventory Net
InventoryNet
27036000
CY2023Q4 us-gaap Inventory Net
InventoryNet
28253000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15275000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10454000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
238509000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
225044000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
89868000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
116228000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13302000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15871000
CY2024Q3 us-gaap Goodwill
Goodwill
28772000
CY2023Q4 us-gaap Goodwill
Goodwill
28772000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
34943000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
40118000
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
35889000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
28002000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5013000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5990000
CY2024Q3 us-gaap Assets
Assets
446296000
CY2023Q4 us-gaap Assets
Assets
460025000
CY2024Q3 us-gaap Secured Debt Current
SecuredDebtCurrent
5964000
CY2023Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
5486000
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1147000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1081000
CY2024Q3 orgo Current Portion Of Operating Lease Obligations Related Party
CurrentPortionOfOperatingLeaseObligationsRelatedParty
6172000
CY2023Q4 orgo Current Portion Of Operating Lease Obligations Related Party
CurrentPortionOfOperatingLeaseObligationsRelatedParty
8413000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3926000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4731000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
23971000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
30724000
CY2024Q3 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
36101000
CY2023Q4 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
30074000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
77281000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
80509000
CY2024Q3 us-gaap Secured Long Term Debt
SecuredLongTermDebt
56153000
CY2023Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
60745000
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1019000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1888000
CY2024Q3 orgo Operating Lease Liability Noncurrent Related Party
OperatingLeaseLiabilityNoncurrentRelatedParty
9217000
CY2023Q4 orgo Operating Lease Liability Noncurrent Related Party
OperatingLeaseLiabilityNoncurrentRelatedParty
11954000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22785000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
25053000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1294000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1213000
CY2024Q3 us-gaap Liabilities
Liabilities
167749000
CY2023Q4 us-gaap Liabilities
Liabilities
181362000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
133305050
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132044944
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132576502
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131316396
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
13000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
13000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
326317000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
319621000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47783000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40971000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
278547000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
278663000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
446296000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
460025000
CY2024Q3 us-gaap Revenues
Revenues
115177000
CY2023Q3 us-gaap Revenues
Revenues
108531000
us-gaap Revenues
Revenues
355387000
us-gaap Revenues
Revenues
333489000
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
26796000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
25789000
us-gaap Cost Of Revenue
CostOfRevenue
84690000
us-gaap Cost Of Revenue
CostOfRevenue
78712000
CY2024Q3 us-gaap Gross Profit
GrossProfit
88381000
CY2023Q3 us-gaap Gross Profit
GrossProfit
82742000
us-gaap Gross Profit
GrossProfit
270697000
us-gaap Gross Profit
GrossProfit
254777000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
71795000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64222000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
220657000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
208373000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10344000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10470000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38741000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32610000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
18842000
orgo Write Down Of Capitalized Internal Use Software Costs
WriteDownOfCapitalizedInternalUseSoftwareCosts
3959000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
82139000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
74692000
us-gaap Operating Expenses
OperatingExpenses
282199000
us-gaap Operating Expenses
OperatingExpenses
240983000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
6242000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
8050000
us-gaap Operating Income Loss
OperatingIncomeLoss
-11502000
us-gaap Operating Income Loss
OperatingIncomeLoss
13794000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
471000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
444000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1605000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1688000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
52000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
47000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
82000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-419000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-413000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1558000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1606000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5823000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7637000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13060000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12188000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6508000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4470000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6248000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6675000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
12331000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
3167000
us-gaap Net Income Loss
NetIncomeLoss
-6812000
us-gaap Net Income Loss
NetIncomeLoss
5513000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132575301
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131312483
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132342203
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131230882
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133926755
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133417721
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132342203
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132790296
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
278663000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
180000
CY2024Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-1120000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2407000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-2100000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
278030000
CY2024Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-54000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2568000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-17043000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
263501000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000
CY2024Q3 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-1000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2712000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
12331000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
278547000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
265669000
CY2023Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-298000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1914000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-2969000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
263701000
CY2023Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-34000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2299000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
5316000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
271282000
CY2023Q3 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-1000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2417000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
3167000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
276865000
us-gaap Profit Loss
ProfitLoss
-6812000
us-gaap Profit Loss
ProfitLoss
5513000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10008000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7466000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2569000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3688000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
6377000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5964000
orgo Non Cash Interest Expense
NonCashInterestExpense
313000
orgo Non Cash Interest Expense
NonCashInterestExpense
321000
orgo Deferred Interest Expense
DeferredInterestExpense
274000
orgo Deferred Interest Expense
DeferredInterestExpense
367000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
3723000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
1320000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7887000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-444000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-104000
orgo Adjustment For Excess And Obsolete Inventories
AdjustmentForExcessAndObsoleteInventories
-5884000
orgo Adjustment For Excess And Obsolete Inventories
AdjustmentForExcessAndObsoleteInventories
-4351000
us-gaap Share Based Compensation
ShareBasedCompensation
7687000
us-gaap Share Based Compensation
ShareBasedCompensation
6630000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
18842000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
orgo Write Down Of Capitalized Internal Use Software Costs
WriteDownOfCapitalizedInternalUseSoftwareCosts
3959000
orgo Write Down Of Capitalized Internal Use Software Costs
WriteDownOfCapitalizedInternalUseSoftwareCosts
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22996000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1761000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5749000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7473000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4052000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4491000
orgo Increase Decrease In Amortization Of Lease Liabilities
IncreaseDecreaseInAmortizationOfLeaseLiabilities
9253000
orgo Increase Decrease In Amortization Of Lease Liabilities
IncreaseDecreaseInAmortizationOfLeaseLiabilities
6282000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6022000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3661000
orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
5882000
orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
8179000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
80000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
68000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3271000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20303000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6671000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21040000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6671000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21040000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
4219000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
3281000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
804000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
114000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1173000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
333000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
184000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6012000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3728000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9412000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4465000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104338000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103290000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94926000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98825000
us-gaap Interest Paid Net
InterestPaidNet
4105000
us-gaap Interest Paid Net
InterestPaidNet
3896000
us-gaap Income Taxes Paid
IncomeTaxesPaid
5493000
us-gaap Income Taxes Paid
IncomeTaxesPaid
3021000
orgo Cumulative Effect Adjustment For Adoption
CumulativeEffectAdjustmentForAdoption
0
orgo Cumulative Effect Adjustment For Adoption
CumulativeEffectAdjustmentForAdoption
615000
orgo Change In Purchases Of Property And Equipment Included In Accounts Payable And Accrued Expenses And Other Current Liabilities
ChangeInPurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
-222000
orgo Change In Purchases Of Property And Equipment Included In Accounts Payable And Accrued Expenses And Other Current Liabilities
ChangeInPurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
4146000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1201000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5138000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported results of operations during the reporting periods. In preparing the condensed consolidated financial statements, the estimates and assumptions that management considers to be significant and that present the greatest amount of uncertainty include: revenue recognition; sales returns and credit losses; inventory reserve; recognition and measurement of current and deferred income tax assets and liabilities; the assessment of recoverability of long-lived assets, including impairment and write-downs; and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the valuation and recognition of stock-based compensation. Actual results and outcomes may differ significantly from those estimates and assumptions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents. The Company invests its cash equivalents in highly rated money market funds. Deposits may exceed federally insured limits, and the Company is exposed to credit risk on deposits in the event of default by the financial institutions to the extent account balances exceed the amount insured by the Federal Deposit Insurance Corporation (FDIC). However, the Company sweeps cash daily overnight and diversifies among financial institutions to reduce such exposure.</span></p>
CY2023Q4 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
5273000
CY2023Q4 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
5273000
CY2024Q3 orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
1476000
orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
4499000
CY2023Q3 orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
1393000
orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
4282000
CY2024Q3 us-gaap Revenues
Revenues
115177000
CY2023Q3 us-gaap Revenues
Revenues
108531000
us-gaap Revenues
Revenues
355387000
us-gaap Revenues
Revenues
333489000
CY2024Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
111002000
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
88859000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9730000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6860000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
101272000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81999000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
8512000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6651000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6860000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6362000
CY2024Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1693000
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1130000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3728000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1320000
CY2024Q3 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-475000
CY2023Q3 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-228000
orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-858000
orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-744000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
9730000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7553000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
9730000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7553000
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13015000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12988000
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1024000
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
810000
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
12997000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
14455000
CY2024Q3 us-gaap Inventory Net
InventoryNet
27036000
CY2023Q4 us-gaap Inventory Net
InventoryNet
28253000
CY2024Q3 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
1415000
orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
5884000
CY2023Q3 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
887000
orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
4351000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
144428000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
130347000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
75166000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
73186000
CY2024Q3 orgo Construction In Progress Net
ConstructionInProgressNet
20606000
CY2023Q4 orgo Construction In Progress Net
ConstructionInProgressNet
59067000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
89868000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
116228000
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3570000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10008000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2544000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7466000
CY2024Q2 orgo Write Down Of Capitalized Internal Use Software Costs
WriteDownOfCapitalizedInternalUseSoftwareCosts
3959000
CY2024Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2024Q3 us-gaap Goodwill
Goodwill
28772000
CY2023Q4 us-gaap Goodwill
Goodwill
28772000
CY2024Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
58523000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
45221000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13302000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
58523000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
42652000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15871000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
834000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2569000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1229000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3688000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22840000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18287000
CY2024Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
7724000
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3075000
CY2024Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
1285000
CY2023Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
2326000
CY2024Q3 orgo Accrued Milestone Payment Current
AccruedMilestonePaymentCurrent
2500000
CY2023Q4 orgo Accrued Milestone Payment Current
AccruedMilestonePaymentCurrent
2500000
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
166000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2799000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1586000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1087000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
36101000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30074000
CY2023Q1 orgo Number Of Reduction In Employees
NumberOfReductionInEmployees
71
CY2023Q1 orgo Percentage Of Reduction In Employees
PercentageOfReductionInEmployees
0.07
us-gaap Severance Costs1
SeveranceCosts1
1609000
CY2023Q3 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
95000
us-gaap Restructuring Charges
RestructuringCharges
1878000
CY2024Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
0
CY2023Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
904000
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
904000
us-gaap Payments For Restructuring
PaymentsForRestructuring
904000
CY2024Q3 us-gaap Restructuring Reserve
RestructuringReserve
0
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
1192000
us-gaap Restructuring Charges
RestructuringCharges
1878000
us-gaap Payments For Restructuring
PaymentsForRestructuring
3056000
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
14000
CY2024Q3 us-gaap Secured Debt
SecuredDebt
62344000
CY2023Q4 us-gaap Secured Debt
SecuredDebt
66563000
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
227000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
332000
CY2024Q3 orgo Secured Debt Net
SecuredDebtNet
62117000
CY2023Q4 orgo Secured Debt Net
SecuredDebtNet
66231000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1406000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
6563000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
54375000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
62344000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9340046
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.6
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M28D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10267000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2640601
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.43
orgo Share Based Compensation Arrangement By Share Based Payment Award Options Total Exercised Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsTotalExercisedNumberOfShares
153750
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.19
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
254000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
166831
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.65
orgo Share Based Compensation Arrangement By Share Based Payment Award Options Canceled And Forfeited In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledAndForfeitedInPeriodIntrinsicValue
166000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11660066
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.39
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M29D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3306000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5516061
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.93
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M18D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2389000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
10637244
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.48
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y7M20D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
3156000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2640601
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3554528
CY2024Q3 us-gaap Profit Loss
ProfitLoss
12331000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
3167000
us-gaap Profit Loss
ProfitLoss
-6812000
us-gaap Profit Loss
ProfitLoss
5513000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132575301
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131312483
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132342203
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131230882
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133926755
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133417721
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132342203
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132790296
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2024Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
1285000
CY2023Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
2326000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.49
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6508000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6248000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4470000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6675000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-125431-index-headers.html Edgar Link pending
0000950170-24-125431-index.html Edgar Link pending
0000950170-24-125431.txt Edgar Link pending
0000950170-24-125431-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img226193477_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
orgo-20240930.htm Edgar Link pending
orgo-20240930.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
orgo-20240930_htm.xml Edgar Link completed
orgo-ex31_1.htm Edgar Link pending
orgo-ex31_2.htm Edgar Link pending
orgo-ex32_1.htm Edgar Link pending
orgo-ex3_3.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending